12.82
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Finanzdaten der Novavax Inc-Aktie (NVAX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
59.36%
56.70
|
139.51 | 147.14 | 70.44 | 239.24 |
| Cost Of Revenue |
53.59%
14.25
|
30.70 | 22.10 | 21.50 | 15.32 |
|
|
7.34%
26.66
|
28.78 | - | - | - |
| Costs And Expenses |
27.97%
111.60
|
154.94 | 132.91 | 248.46 | 138.17 |
| Depreciation and Amortization |
0.20%
3.056
|
3.062 | 5.125 | 6.585 | 7.563 |
| Operating Income/Loss |
255.84%
-54.91
|
-15.43 | 14.23 | -178.02 | 101.07 |
| Income/Loss From Continuing Operations Before Tax |
507.52%
-51.68
|
-8.506 | 17.90 | -203.04 | 107.45 |
| Income Tax Expense/Benefit |
73.71%
1.711
|
0.985 | 0.376 | -0.657 | 0.946 |
|
|
462.50%
-53.39
|
-9.491 | 17.53 | -202.38 | 106.51 |
| Basic Average Shares |
0.79%
164.57
|
163.28 | 0.18 | 162.35 | 162.02 |
| Diluted Average Shares |
0.79%
164.57
|
163.28 | 4.908 | 162.35 | 177.22 |
| Basic Earnings Per Share |
433.33%
-0.32
|
-0.06 | 0.11 | -1.25 | 0.66 |
| Diluted Earnings Per Share |
433.33%
-0.32
|
-0.06 | 0.05 | -1.25 | 0.62 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):